vs
Cohen & Co Inc.（COHN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Cohen & Co Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$102.7M vs $75.5M），Cohen & Co Inc.同比增速更快（454.1% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-2.5M），过去两年Cohen & Co Inc.的营收复合增速更高（135.3% vs 31.3%）
科恩父子公司是一家总部位于伦敦商业路的废金属贸易商，由乔治·亨利·科恩于1834年创立，最初名为乔治·科恩公司，1883年创始人之子迈克尔·科恩入职后更名为现名。一战结束后，公司拿下多份大型合同，负责处理包括40万吨烈性炸药及炮弹在内的剩余军火。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
COHN vs PBYI — 直观对比
营收规模更大
COHN
是对方的1.4倍
$75.5M
营收增速更快
COHN
高出426.4%
27.7%
自由现金流更多
PBYI
多$16.9M
$-2.5M
两年增速更快
COHN
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $102.7M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 29.2% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 454.1% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.77 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COHNPBYI
| Q4 25 | $102.7M | $75.5M | ||
| Q3 25 | $84.2M | $54.5M | ||
| Q2 25 | $59.9M | $52.4M | ||
| Q1 25 | $28.7M | $46.0M | ||
| Q4 24 | $18.5M | $59.1M | ||
| Q3 24 | $31.7M | $80.5M | ||
| Q2 24 | $10.8M | $47.1M | ||
| Q1 24 | $18.6M | $43.8M |
净利润COHNPBYI
| Q4 25 | — | — | ||
| Q3 25 | $4.6M | $8.8M | ||
| Q2 25 | $1.4M | $5.9M | ||
| Q1 25 | $329.0K | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.1M | $20.3M | ||
| Q2 24 | $-2.3M | $-4.5M | ||
| Q1 24 | $2.0M | $-4.8M |
毛利率COHNPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率COHNPBYI
| Q4 25 | 29.2% | 22.7% | ||
| Q3 25 | 25.8% | 17.6% | ||
| Q2 25 | 12.5% | 12.7% | ||
| Q1 25 | 0.4% | 8.7% | ||
| Q4 24 | -29.7% | 22.6% | ||
| Q3 24 | 22.8% | 27.4% | ||
| Q2 24 | -59.0% | -4.6% | ||
| Q1 24 | -18.2% | -5.3% |
净利率COHNPBYI
| Q4 25 | — | — | ||
| Q3 25 | 5.5% | 16.2% | ||
| Q2 25 | 2.4% | 11.2% | ||
| Q1 25 | 1.1% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.8% | 25.2% | ||
| Q2 24 | -21.8% | -9.6% | ||
| Q1 24 | 10.9% | -11.0% |
每股收益（稀释后）COHNPBYI
| Q4 25 | $0.77 | $0.26 | ||
| Q3 25 | $2.58 | $0.17 | ||
| Q2 25 | $0.81 | $0.12 | ||
| Q1 25 | $0.19 | $0.06 | ||
| Q4 24 | $-1.20 | $0.40 | ||
| Q3 24 | $1.31 | $0.41 | ||
| Q2 24 | $-1.47 | $-0.09 | ||
| Q1 24 | $1.28 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $56.8M | $97.5M |
| 总债务越低越好 | $32.9M | $22.7M |
| 股东权益账面价值 | $51.1M | $130.3M |
| 总资产 | $700.6M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.64× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资COHNPBYI
| Q4 25 | $56.8M | $97.5M | ||
| Q3 25 | $54.7M | $94.4M | ||
| Q2 25 | $26.0M | $96.0M | ||
| Q1 25 | $14.0M | $93.2M | ||
| Q4 24 | $19.6M | $101.0M | ||
| Q3 24 | $14.3M | $96.7M | ||
| Q2 24 | $9.6M | $96.8M | ||
| Q1 24 | $11.8M | $107.2M |
总债务COHNPBYI
| Q4 25 | $32.9M | $22.7M | ||
| Q3 25 | $32.7M | $34.0M | ||
| Q2 25 | $32.6M | $45.3M | ||
| Q1 25 | $35.0M | $56.7M | ||
| Q4 24 | $34.9M | $68.0M | ||
| Q3 24 | $34.9M | $79.3M | ||
| Q2 24 | $29.7M | $90.7M | ||
| Q1 24 | $29.7M | $102.0M |
股东权益COHNPBYI
| Q4 25 | $51.1M | $130.3M | ||
| Q3 25 | $47.8M | $115.3M | ||
| Q2 25 | $43.4M | $104.7M | ||
| Q1 25 | $42.0M | $97.1M | ||
| Q4 24 | $41.7M | $92.1M | ||
| Q3 24 | $43.8M | $71.1M | ||
| Q2 24 | $41.7M | $48.5M | ||
| Q1 24 | $43.8M | $51.0M |
总资产COHNPBYI
| Q4 25 | $700.6M | $216.3M | ||
| Q3 25 | $773.9M | $202.9M | ||
| Q2 25 | $1.1B | $194.9M | ||
| Q1 25 | $978.0M | $196.2M | ||
| Q4 24 | $971.1M | $213.3M | ||
| Q3 24 | $818.0M | $220.7M | ||
| Q2 24 | $826.0M | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
负债/权益比COHNPBYI
| Q4 25 | 0.64× | 0.17× | ||
| Q3 25 | 0.68× | 0.30× | ||
| Q2 25 | 0.75× | 0.43× | ||
| Q1 25 | 0.83× | 0.58× | ||
| Q4 24 | 0.84× | 0.74× | ||
| Q3 24 | 0.80× | 1.12× | ||
| Q2 24 | 0.71× | 1.87× | ||
| Q1 24 | 0.68× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $14.4M |
| 自由现金流率自由现金流/营收 | -2.4% | 19.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $26.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流COHNPBYI
| Q4 25 | $-2.1M | $14.4M | ||
| Q3 25 | $22.4M | $9.7M | ||
| Q2 25 | $13.3M | $14.1M | ||
| Q1 25 | $-6.4M | $3.6M | ||
| Q4 24 | $4.4M | $15.6M | ||
| Q3 24 | $4.1M | $11.0M | ||
| Q2 24 | $-4.2M | $1.0M | ||
| Q1 24 | $5.1M | $11.2M |
自由现金流COHNPBYI
| Q4 25 | $-2.5M | $14.4M | ||
| Q3 25 | $22.2M | $9.7M | ||
| Q2 25 | $12.9M | $14.1M | ||
| Q1 25 | $-6.5M | $3.6M | ||
| Q4 24 | $4.0M | $15.6M | ||
| Q3 24 | $3.8M | $11.0M | ||
| Q2 24 | $-4.6M | $1.0M | ||
| Q1 24 | $5.0M | — |
自由现金流率COHNPBYI
| Q4 25 | -2.4% | 19.1% | ||
| Q3 25 | 26.3% | 17.7% | ||
| Q2 25 | 21.6% | 26.8% | ||
| Q1 25 | -22.7% | 7.7% | ||
| Q4 24 | 21.4% | 26.4% | ||
| Q3 24 | 12.0% | 13.7% | ||
| Q2 24 | -42.4% | 2.1% | ||
| Q1 24 | 27.1% | — |
资本支出强度COHNPBYI
| Q4 25 | 0.4% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 2.5% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 3.5% | 0.0% | ||
| Q1 24 | 0.5% | 0.0% |
现金转化率COHNPBYI
| Q4 25 | — | — | ||
| Q3 25 | 4.88× | 1.10× | ||
| Q2 25 | 9.48× | 2.41× | ||
| Q1 25 | -19.37× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.91× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COHN
| Capital Markets | $68.5M | 67% |
| Other | $25.7M | 25% |
| Gestational Repo Business | $5.6M | 5% |
| Asset Management Segment | $2.9M | 3% |
PBYI
暂无分部数据
